PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Laboratory of Emergency Medicine, Tianjin Union Medical Centre, Tianjin, China.\', \'Graduate School of Tianjin Medical University, Tianjin, China.\', \'Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.\', \'Unicell Life Science Development Co., Ltd, Tianjin, China.\', \'Department of Clinical Laboratory Medicine, the Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7150/ijms.53564
?:hasPublicationType
?:journal
  • International journal of medical sciences
is ?:pmid of
?:pmid
?:pmid
  • 33628091
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.9
?:rankingScore_hIndex
  • 45
is ?:relation_isRelatedTo_publication of
?:title
  • Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all